Secure and Distributed Assessment of Privacy-Preserving Releases of GWAS
T\'ulio Pascoal, J\'er\'emie Decouchant, Marcus V\"olp

TL;DR
This paper introduces GenDPR, a distributed middleware leveraging Trusted Execution Environments to securely and privately determine which GWAS results can be safely released, aligning with privacy regulations and reducing data transfer.
Contribution
GenDPR is a novel middleware that enables privacy-preserving GWAS result sharing without a central authority, using TEEs for secure, efficient, and regulatory-compliant data release.
Findings
GenDPR matches centralized accuracy in GWAS result disclosure.
It significantly reduces data transfer by exchanging only intermediary results.
It tolerates collusion of all-but-one federation members to protect genomes.
Abstract
Genome-wide association studies (GWAS) identify correlations between the genetic variants and an observable characteristic such as a disease. Previous works presented privacy-preserving distributed algorithms for a federation of genome data holders that spans multiple institutional and legislative domains to securely compute GWAS results. However, these algorithms have limited applicability, since they still require a centralized instance to decide whether GWAS results can be safely disclosed, which is in violation to privacy regulations, such as GDPR. In this work, we introduce GenDPR, a distributed middleware that leverages Trusted Execution Environments (TEEs) to securely determine a subset of the potential GWAS statistics that can be safely released. GenDPR achieves the same accuracy as centralized solutions, but requires transferring significantly less data because TEEs only…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRenal Transplantation Outcomes and Treatments · Cancer Genomics and Diagnostics · Genomics and Rare Diseases
